Journal article
Switching Therapy in Health Economics Trials: Confronting the Confusion
Abstract
Should patients in a randomized, pragmatic health economics trial be allowed to switch therapy in mid-trial to that provided in the other arm? Specifically, should patients in the treatment arm (T) be allowed to switch to the therapy of the comparator arm (C) if they need a change of therapy--that is, should TC switches be allowed? Also, should patients in the comparator arm be allowed to switch to the therapy of the treatment arm if they need …
Authors
Torrance GW; Drummond MF; Walker V
Journal
Medical Decision Making, Vol. 23, No. 4, pp. 335–340
Publisher
SAGE Publications
Publication Date
7 2003
DOI
10.1177/0272989x03256007
ISSN
0272-989X